IL130954A0 - Neurturin receptor - Google Patents

Neurturin receptor

Info

Publication number
IL130954A0
IL130954A0 IL13095498A IL13095498A IL130954A0 IL 130954 A0 IL130954 A0 IL 130954A0 IL 13095498 A IL13095498 A IL 13095498A IL 13095498 A IL13095498 A IL 13095498A IL 130954 A0 IL130954 A0 IL 130954A0
Authority
IL
Israel
Prior art keywords
ntnr
alpha
antibodies
neurturin receptor
neurturin
Prior art date
Application number
IL13095498A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/802,805 external-priority patent/US6372453B1/en
Priority claimed from US08/957,063 external-priority patent/US6025157A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL130954A0 publication Critical patent/IL130954A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13095498A 1997-02-18 1998-12-17 Neurturin receptor IL130954A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/802,805 US6372453B1 (en) 1997-02-18 1997-02-18 Neurturin receptor
US87191397A 1997-06-09 1997-06-09
US08/957,063 US6025157A (en) 1997-02-18 1997-10-24 Neurturin receptor
PCT/US1998/003179 WO1998036072A1 (en) 1997-02-18 1998-02-17 Neurturin receptor

Publications (1)

Publication Number Publication Date
IL130954A0 true IL130954A0 (en) 2001-01-28

Family

ID=27419991

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13095498A IL130954A0 (en) 1997-02-18 1998-12-17 Neurturin receptor
IL130954A IL130954A (en) 1997-02-18 1999-07-15 HUMAN NEURTURIN RECEPTOR- a (NTNR a ) POLYPEPTIDES, ANTIBODIES TO NTNR a AND COMPOSITION COMPRISING THE SAME

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL130954A IL130954A (en) 1997-02-18 1999-07-15 HUMAN NEURTURIN RECEPTOR- a (NTNR a ) POLYPEPTIDES, ANTIBODIES TO NTNR a AND COMPOSITION COMPRISING THE SAME

Country Status (10)

Country Link
EP (1) EP1007666B1 (de)
JP (1) JP4086324B2 (de)
AT (1) ATE312915T1 (de)
AU (1) AU730430B2 (de)
CA (1) CA2281620C (de)
DE (1) DE69832797T2 (de)
DK (1) DK1007666T3 (de)
ES (1) ES2258295T3 (de)
IL (2) IL130954A0 (de)
WO (1) WO1998036072A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696259B1 (en) 1995-11-13 2004-02-24 Licentia Ltd. Assays using glial cell line-derived neurotrophic factor receptors
US6677135B1 (en) 1996-05-08 2004-01-13 Biogen, Inc. Ret ligand (RetL) for stimulating neutral and renal growth
NZ501423A (en) * 1997-04-17 2002-02-01 Univ Washington Receptors for TGF-beta-related neurotrophic factors and use for treating disease
JP2001527418A (ja) * 1997-05-22 2001-12-25 セフアロン・インコーポレーテツド グリア細胞系由来の神経栄養因子レセプター
JP2002505576A (ja) * 1997-05-30 2002-02-19 アムジエン・インコーポレーテツド 神経栄養因子レセプター
NZ506748A (en) * 1998-03-23 2002-10-25 Genentech Inc Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production
WO2000020867A1 (en) * 1998-10-01 2000-04-13 Alexey Vladimirovich Titievsky A novel ret-independent signaling pathway for gdnf
US6905817B1 (en) 1998-10-01 2005-06-14 Licestia Ltd. Ret-independent signaling pathway for GDNF
FI991197A0 (fi) * 1999-05-27 1999-05-27 Mart Saarma Neurotrooppiset tekijät lantionalueen ääreishermoston toimintahäiriön hoitamisessa
JP4838724B2 (ja) * 2003-11-27 2011-12-14 デヴェロゲン アクチエンゲゼルシャフト ニュールツリンを用いる糖尿病の予防と治療方法
CN104220461A (zh) * 2011-12-29 2014-12-17 Atyr医药公司 天冬氨酰-tRNA合成酶-FC缀合物
WO2025206402A1 (ja) * 2024-03-29 2025-10-02 株式会社沖縄Ukami養蚕 アフリカ豚熱ワクチン産生組換えエリ蚕及びその利用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126918A (en) * 1996-05-08 2007-06-03 Biogen Idec Inc Ret ligand (retl) for stimulating neural and renal growth

Also Published As

Publication number Publication date
WO1998036072A1 (en) 1998-08-20
CA2281620C (en) 2012-05-01
CA2281620A1 (en) 1998-08-20
DE69832797T2 (de) 2006-08-17
AU730430B2 (en) 2001-03-08
AU6175098A (en) 1998-09-08
IL130954A (en) 2008-11-26
ES2258295T3 (es) 2006-08-16
DE69832797D1 (de) 2006-01-19
DK1007666T3 (da) 2006-05-08
EP1007666A1 (de) 2000-06-14
JP2002511738A (ja) 2002-04-16
EP1007666B1 (de) 2005-12-14
JP4086324B2 (ja) 2008-05-14
ATE312915T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
DK0888385T3 (da) GDNF receptor og anvendelser deraf
MX9709324A (es) Compuestos terapeuticos que comprenden anticuerpos anti receptores fc.
PT800519E (pt) Compostos moduladores de receptores de esteroides e metodos
ATE312915T1 (de) Neurturin-rezeptor
MX9704640A (es) Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion.
AU4622297A (en) Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
WO2000070049A3 (en) Extracellular signaling molecules
MX9603928A (es) Receptores trk humanos e inhibidores del factor neurotrofico.
TW200607814A (en) Cell surface receptor isoforms and methods of identifying and using the same
WO1999000410A3 (en) Human extracellular matrix proteins
WO2002046228A3 (en) Receptor for b. anthracis toxin
YU41998A (sh) Tetrahidrobetakarbolinska jedinjenja
WO1995007934A3 (en) Il8 inhibitors
WO2002039118A8 (en) Screening methods for bone morphogenetic mimetics
AU2001266975A1 (en) G-protein coupled receptors
AUPN646795A0 (en) Neuropeptide Y-Y5 receptor
WO1999057270A3 (en) Human receptor molecules
WO1995016709A3 (en) Anti-mullerian hormone receptor polypeptides and antibodies thereto
GB2328625B (en) Heating unit for vaporizing sample by heating
ZA988637B (en) Methods for regulating trkA expression.
PT1056850E (pt) Moleculas receptoras de ligacao a biotina
WO2004069859A3 (en) Restoring function to gonadotropin releasing hormone receptor mutants
WO2004070347A3 (en) Screening for modulators of fat storage
WO1999043807A3 (en) Human channel-related molecules
WO2000042172A3 (en) Human homologues of proteins regulated by circadian rhythms

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed